Benefits of Semaglutide Semaglutides unique mechanism of action mimics the effects of GLP-1, a hormone that helps regulate insulin production and appetite
Health BPC-157 and KPV may support gut integrity and digestive health by helping modulate inflammation and protect the gut lining
Common gastrointestinal side effects include: Nausea and vomiting : Usually most pronounced during initial treatment and dose escalation, often improving over 48 weeks Diarrhoea or constipation : Can affect hydration and nutritional status Abdominal discomfort : Typically mild and transient Patients can manage mild gastrointestinal symptoms by eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking the medication as directed
Rather, theyre part of a broader wellness toolkit, especially for those looking to reduce reliance on prescription medications or manage weight more sustainably
Patients who may particularly benefit from the oral option include: Those with needle concerns: While modern GLP-1 injections use very small needles, some patients have significant needle phobia that prevents them from starting treatment Patients seeking a less medical approach: Some individuals prefer the familiarity of taking a daily pill over self-injecting Weight maintenance candidates: Emerging research suggests oral GLP-1s may be effective for maintaining weight loss after achieving goals on injectable medications Those with access challenges: Pills dont require refrigeration and may be easier to travel with Important Considerations Before Switching or Starting The Wegovy pill will be available in January 2026, with the starting 1.5mg dose priced at $149 per month for cash-paying patients